Search results
Analysis | Four questions for today’s Fauci hearing
Washington Post· 3 days agoThe Texas Supreme Court rejected a lawsuit that sought to clarify exceptions to the state’s abortion laws. The longtime infectious-disease expert is back...
Chinese military covertly woos Western pilots to train PLA flyers
The Washington Times· 23 hours agoU.S. and allied intelligence services warned current and former military personnel this week that...
Daily briefing: Anthony Fauci denies ‘preposterous’ accusations of COVID origins cover-up
Nature· 3 days agoFauci, the face of the US pandemic response, was in the hot-seat at a politically polarized hearing....
1st Circuit Seems Unsure of Overturning Order Barring American Airlines-JetBlue Alliance | National...
Law.com· 3 days agoA U.S. Court of Appeals for the First Circuit panel seemed skeptical Monday of overturning an order...
Californians with Disabilities Face Barriers When Voting, Even After Bills and Lawsuits | KQED
KQED· 23 hours agoCalifornia has been hailed by state officials and some voting rights advocates as a national leader...
AP News in Brief at 11:04 p.m. EDT
Bozeman Daily Chronicle· 3 days agoIndia on Tuesday began counting more than 640 million votes in the world’s largest democratic exercise, which was widely expected to return Prime Minister Narendra Modi to a third term after ...
Moderna nears deal with US government to receive funding for bird flu vaccine, report says - The...
The Boston Globe· 7 days agoModerna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine,...
Takeaways from Tallahassee — It’s prep time
Florida Politics· 5 days agoAnother disaster preparedness sales tax holiday will run from Aug. 24 through Sept. 6. The holidays were part of the tax cut package (HB 7073) signed by...
Greater focus on crime sparks another wave of juvenile justice bills
The State· 2 days agoCriminal justice advocates warn that strict new policies could roll back previous overhauls of the system. This year, states including Connecticut, Kansas, Kentucky, Louisiana, Maryland, < ...
'Outstanding' 5 Year PFS With Lorlatinib in ALK+ NSCLC
Medscape· 6 days agoFive-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.